2025 Hyper Recent •CC0 1.0 Universal

This work is dedicated to the public domain. No rights reserved.

Access Preprint From Server
April 3rd, 2025
Version: 1
Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts, 02129, USA
cancer biology
biorxiv

Epitope Expression Persists in Circulating Tumor Cells as Breast Cancers Acquire Resistance to Antibody Drug Conjugates

Mishra, A.Open in Google Scholar•Abelman, R.Open in Google Scholar•Cunneely, Q.Open in Google Scholar•Putaturo, V.Open in Google Scholar•Deshpande, A. A.Open in Google Scholar•Bell, R.Open in Google Scholar•Seider, E. M.Open in Google Scholar•Xu, K. H.Open in Google Scholar•Shan, M.Open in Google Scholar•Kelly, J.Open in Google Scholaret al.

Antibody-drug conjugates (ADCs) targeting cell surface proteins TROP2 or HER2 are effective in metastatic breast cancer, but the precise clinical contribution of epitope expression is uncertain. We prospectively monitored circulating tumor cells (CTCs) in 33 patients receiving ADC therapies using quantitative imaging. The expression of TROP2 and HER2 are heterogeneous across single CTCs from untreated patients, comparable to matched tumor biopsies, and display poor association with clinical response. Within three weeks of treatment initiation, declining CTC numbers correlate with a durable response (TROP2: median time to progression 391 versus 97 days, HR 4.15, P=0.0046; HER2: 322 versus 66 days, HR 9.12, P=0.0002). Neither TROP2 nor HER2 expression is reduced at progression, compared to matched pretreatment CTCs, and switching ADC epitope while maintaining a similar payload shows poor efficacy. Thus, epitope downregulation is not a common driver of acquired resistance to TROP2 or HER2 ADCs, and second-line ADC therapies may benefit from distinct payloads.

Similar Papers

biorxiv
Thu Apr 03 2025
Discovery and therapeutic exploitation of Master Regulatory miRNAs in Glioblastoma
Glioblastoma is a fatal primary malignant brain tumor. Despite therapies involving surgical resection, chemotherapy, and radiation therapy, the average survival for glioblastoma patients remains at approximately 15 months. MicroRNAs (miRNAs) are short noncoding RNA molecules that regulate the expression of the majority of human genes. Numerous genes are concurrently deregulated in glioblastoma. Co...
Abounader, R.
•
Saha, S.
•
Zhang, Y.
•
Gibert, M. K.
...•
Hafner, M.
biorxiv
Thu Apr 03 2025
Single cell transcriptional evolution of myeloid leukaemia of Down syndrome
Children with Down syndrome have a 150-fold increased risk of developing myeloid leukaemia (ML-DS). Unusually for a childhood leukaemia, ML-DS arises from a preleukaemic state, termed transient abnormal myelopoiesis (TAM), via a conserved sequence of mutations. Here, we examined the relationship between the genetic and transcriptional evolution of ML-DS from natural variation; a rich collection of...
Trinh, M. K.
•
Schuschel, K.
•
Issa, H.
•
Thomas, R.
...•
Behjati, S.
biorxiv
Thu Apr 03 2025
DANEELpath: Open-source Digital analysis tools for histopathological research. Applications in NEuroblastoma modELs
Despite the considerable expansion of bioimage analysis as a subfield of biomedical sciences, there is an ongoing need for comprehensive image analysis pipelines to address specific biological inquiries. In the tumor microenvironment, the extracellular matrix (ECM) plays a pivotal role in cancer progression, promoting tumor cell adaptability, intratumor heterogeneity, and therapeutic resistance. I...
Vieco-Marti, I.
•
Lopez-Carrasco, A.
•
Navarro, S.
•
Granados-Aparici, S.
•
Noguera, R.
biorxiv
Thu Apr 03 2025
The molecular chaperone TRAP1 promotes translation of Luc7l3 mRNA to enhance ovarian cancer cell proliferation
Heat shock proteins have been increasingly identified in RNA-interactomes, suggesting potential roles beyond their canonical functions. Among those, the cancer-linked chaperone TRAP1 has been mainly characterized for its regulatory role on respiratory complex activity and protein synthesis, while its specific function as an RNA-binding protein (RBP) remains unclear. In this study, we confirmed the...
De Lella, S.
•
Pedalino, L.
•
Almagboul Abdalla Abaker, M.
•
Mignogna, C.
...•
Avolio, R.
biorxiv
Thu Apr 03 2025
An LC-MS/MS method for the quantification of tobacco-specific carcinogen protein adducts.
4-(Methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and its major metabolite 4- (methylnitrosamino)-l-(3-pyridine)-l-butanol (NNAL) are tobacco-specific lung carcinogens. Methods have been developed to quantify NNK- and NNAL-specific DNA adducts in pre-clinical samples but are less feasible to translation due to limited access to target tissues for sufficient DNA. NNAL-specific DNA or protein ad...
Xing, C.
•
Freeman, B. N.
biorxiv
Thu Apr 03 2025
Single cell spatial transcriptomics identifies coordinated cellular programs that are associated with good prognosis in microsatellite stable colorectal cancer
It has been reported that microsatellite instable (MSI) tumors in colorectal cancer (CRC) exhibit stronger anti-tumor immune responses than microsatellite stable (MSS) tumors. Using a simple classification system we recently showed that MSS tumors with both high numbers of tumor-associated macrophages (TAMs) and T cells had good prognosis, whereas high numbers of TAMs and low numbers of T cells ha...
Karlsen, V. T.
•
Majid, U.
•
Lindholm, H. T.
•
Umu, S. U.
...•
Jahnsen, F. L.
biorxiv
Thu Apr 03 2025
WEE1 inhibitors trigger GCN2-mediated activation of the integrated stress response
The WEE1 kinase negatively regulates CDK1/2 to control DNA replication and mitotic entry. Genetic factors that determine sensitivity to WEE1 inhibitors (WEE1i) are largely unknown. A genome-wide insertional mutagenesis screen revealed that mutation of EIF2A, a translation regulator, sensitized to WEE1i. Mechanistically, WEE1i treatment triggers a translational shut-down, which is lethal in combina...
Tjeerdsma, R. B.
•
Ng, T.
•
Roorda, M.
•
Bianchi, D.
...•
van Vugt, M.
biorxiv
Thu Apr 03 2025
Presence of Hepatitis B virus infection in colon cancer
Hepatitis B virus (HBV) infection affects ~300 million people worldwide, which population is at an elevated risk of various cancers, such as gastrointestinal cancer, while the matter behind is largely unclear. In this study, we analyzed 10 colonic specimens from 6 colon cancer patients who were also chronic HBV carriers through Fluorescence-activated Cell Sorting and Immunofluorescence assay to in...
Li, L.
•
Gong, W.
•
An, Y.
•
Tong, H.
...•
Sun, K.
biorxiv
Thu Apr 03 2025
The glycosyltransferase ALG3 is an AKT substrate that regulates protein N-glycosylation
The PI3K/AKT signaling pathway is frequently dysregulated in cancer and controls key cellular processes such as survival, proliferation, metabolism and growth. Protein glycosylation is essential for proper protein folding and is also often deregulated in cancer. Cancer cells depend on increased protein folding to sustain oncogene-driven proliferation rates. The N-glycosyltransferase asparagine-lin...
Navarro-Traxler, A. J.
•
Ghisolfi, L.
•
Lien, E. C.
•
Toker, A.